We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+2.16%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$34.7B
AUM Growth
+$242M
(+0.7%)
Cap. Flow
-$120M
Cap. Flow
% of AUM
-0.35%
Top 10 Holdings %
Top 10 Hldgs %
14.95%
Holding
3,089
New
65
Increased
2,336
Reduced
597
Closed
54
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$47.6M |
| 2 |
Medtronic
MDT
|
+$41.4M |
| 3 |
SLB Ltd
SLB
|
+$25M |
| 4 |
American Airlines Group
AAL
|
+$19.2M |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$18.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan Inc
AGN
|
+$107M |
| 2 |
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
|
+$68.5M |
| 3 |
Apple
AAPL
|
+$22.9M |
| 4 |
CFN
CAREFUSION CORPORATION
CFN
|
+$16.9M |
| 5 |
PETM
PETSMART INC
PETM
|
+$14M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.74% |
| 2 | Financials | 14.67% |
| 3 | Healthcare | 14.62% |
| 4 | Industrials | 10.93% |
| 5 | Consumer Discretionary | 9.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AEGR
2026
DELISTED
Aegerion Pharmaceuticals
AEGR
| $772K | ﹤0.01% |
29,513
+4,000
| +16% | +$102K |
|
|
RAS
2027
DELISTED
RAIT Financial Trust
RAS
| $772K | ﹤0.01% |
112,562
+4,800
| +4% | +$34.3K |
|
2028
Mizuho Financial
MFG
$130B
| $770K | ﹤0.01% |
217,015
+65,455
| +43% | +$230K |
|
2029
Chegg
CHGG
$103M
| $768K | ﹤0.01% |
96,635
+1,200
| +1% | +$8.91K |
|
2030
Park Aerospace
PKE
$819M
| $768K | ﹤0.01% |
35,630
+1,400
| +4% | +$30.5K |
|
2031
Winnebago Industries
WGO
$909M
| $766K | ﹤0.01% |
36,049
+3,575
| +11% | +$77.1K |
|
2032
Sonida Senior Living
SNDA
$1.91B
| $765K | ﹤0.01% |
1,966
+275
| +16% | +$101K |
|
2033
Sabre
SABR
$818M
| $764K | ﹤0.01% |
31,447
-360
| -1% | -$7.71K |
|
|
MITT
2034
TPG Mortgage Investment Trust
MITT
$225M
| $763K | ﹤0.01% |
13,499
+700
| +5% | +$39.2K |
|
|
DVAX
2035
DELISTED
Dynavax Technologies
DVAX
| $761K | ﹤0.01% |
33,922
+300
| +0.9% | +$5.75K |
|
|
ISSI
2036
DELISTED
INTEGRATED SILICON SOLUTN INC
ISSI
| $761K | ﹤0.01% |
42,521
+800
| +2% | +$13.4K |
|
|
VTLE
2037
DELISTED
Vital Energy
VTLE
| $756K | ﹤0.01% |
2,898
+95
| +3% | +$21.6K |
|
2038
Rio Tinto
RIO
$164B
| $755K | ﹤0.01% |
18,229
+343
| +2% | +$15.5K |
|
|
HTLF
2039
DELISTED
Heartland Financial USA, Inc.
HTLF
| $754K | ﹤0.01% |
23,105
+600
| +3% | +$17.8K |
|
2040
StoneX
SNEX
$7.94B
| $752K | ﹤0.01% |
128,021
+3,291
| +3% | +$15.8K |
|
|
LFC
2041
DELISTED
China Life Insurance Company Ltd.
LFC
| $752K | ﹤0.01% |
34,161
-2,889
| -8% | -$58.9K |
|
|
SUP
2042
DELISTED
Superior Industries International
SUP
| $750K | ﹤0.01% |
39,608
+800
| +2% | +$15.2K |
|
2043
DXP Enterprises
DXPE
$2.98B
| $749K | ﹤0.01% |
16,984
+2,125
| +14% | +$94.9K |
|
2044
Green Dot
GDOT
$745M
| $748K | ﹤0.01% |
46,976
+1,500
| +3% | +$25.6K |
|
|
AMTG
2045
DELISTED
APOLLO RESIDENTIAL MTG INC COM STK
AMTG
| $748K | ﹤0.01% |
46,898
+1,100
| +2% | +$17.4K |
|
|
BT
2046
DELISTED
BT Group plc (ADR)
BT
| $747K | ﹤0.01% |
22,920
-140
| -0.6% | -$4.62K |
|
2047
Coca-Cola Consolidated
COKE
$12.8B
| $746K | ﹤0.01% |
65,950
+8,230
| +14% | +$83.5K |
|
2048
Mercury Systems
MRCY
$6.52B
| $745K | ﹤0.01% |
47,932
-300
| -0.6% | -$4.74K |
|
|
RDEN
2049
DELISTED
ELIZABETH ARDEN INC
RDEN
| $745K | ﹤0.01% |
47,735
+600
| +1% | +$9.99K |
|
2050
Central Garden & Pet Co Class A
CENTA
$2.44B
| $744K | ﹤0.01% |
87,561
+4,625
| +6% | +$37.1K |
|
Similar funds
VAM
RhumbLine Advisers's Q1 2015 Portfolio in Review
As of Q1 2015, RhumbLine Advisers held 3,089 positions worth $34.7B, up 0.7% from $34.4B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Trading was light in Q1 2015: portfolio turnover was 3.9%. RhumbLine Advisers opened 65 new positions and exited 54, leaving the 3,089-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 15% a quarter earlier, followed by Financials and Healthcare.
- RhumbLine Advisers's largest Q1 2015 buy was Qorvo: 254,331 shares worth $20.3M.
- RhumbLine Advisers added most to Allergan plc in Q1 2015, an estimated $47.6M increase.
- RhumbLine Advisers's biggest Q1 2015 reduction was Apple, cutting an estimated $22.9M.
- RhumbLine Advisers fully exited Allergan Inc in Q1 2015, selling an estimated $107M.
- RhumbLine Advisers's ten largest holdings make up 15% of its $34.7B portfolio in Q1 2015.
- RhumbLine Advisers opened 65 new positions and closed 54 in Q1 2015.
- RhumbLine Advisers's portfolio value rose 0.7% quarter-over-quarter to $34.7B.
Based on RhumbLine Advisers's 13F filing for Q1 2015, filed 12 May 2015.